**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 65-45-2 |Salicylamide | 99 | 200-609-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Overexposure may produce CNS depression, hypotension, eventually
respiratory arrest, but does not produce excitement, seizures,
acidosis, or hypoprothrombinemia. Severe salicylate intoxication may
cause central nervous system disturbances such as convulsions and
coma, skin eruptions, and alteration in the acid-base balance.
Inhalation:
Inhalation of dust may cause respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 65-45-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white
Odor: practically odorless
pH: 5 (0.2% aq soln)
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 270 deg C (dec)
Freezing/Melting Point: 139-142 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 270 deg C
Solubility in water: Soluble in hot water.
Specific Gravity/Density: Not available.
Molecular Formula: C7H7NO2
Molecular Weight: 137.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. May discolor on
exposure to light.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 65-45-2: VN6475000
LD50/LC50:
CAS# 65-45-2: Draize test, rabbit, eye: 100 mg/24H Moderate; Oral,
mouse: LD50 = 300 mg/kg; Oral, rabbit: LD50 = 3200 mg/kg; Oral, rat:
LD50 = 980 mg/kg.
Not available.
Carcinogenicity:
Salicylamide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 65-45-2: 2
Canada
CAS# 65-45-2 is listed on Canada's DSL List.
CAS# 65-45-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 65-45-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/24/1999 Revision #3 Date: 12/04/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
1,1',3,3,3',3'-Hexamethyl-4,4',5,5'-dibenzo-2,2'-indotricarbocyanine
| 23178-67-8 |
|
1-Bromooctane, 97% (gc)
| 111-83-1 |
|
n-Octyl 4-chloroacetoacetate, tech. 85%
| 41051-21-2 |
|
Magnesium Hydroxide
| 1309-42-8 |
|
5-Nitrosalicylic Acid, 99%
| 96-97-9 |
|
Quinaldine red, 99% (uv-vis)
| 117-92-0 |
|
Silver nitrite, 99%
| 7783-99-5 |
|
Magnesium nitrate hexahydrate
| 10377-60-3 |
|
2,4-Dichloronitrobenzene, 97%
| 611-06-3 |
|
Magnesium Oxide
| 1309-48-4 |
|
Magnesium Perchlorate Anhydrous
| 10034-81-8 |
|
Pyrrole, 99%
| 109-97-7 |
|
Dextro,levo-10-camphorsulfonic acid, sodium salt, 98%
| 34850-66-3 |
|
2-Amino-4,6-Dihydroxy-5-Methylpyrimidine 99%
| 55477-35-3 |
|
N-Carbobenzyloxy-L-Valine, 99+%
| 1149-26-4 |
|
Calcium bromide dihydrate, 99+%
| 7789-41-5 |
|
Phenyl Acridine-9-Carboxylate
| 109392-90-7 |
|
(R,R)-(-)-2,3-Dimethoxy-1,4-Bis(Dimethylamino)Butane, 96%
| 26549-22-4 |
|
Magnesium sulfate anhydrous
| 7487-88-9 |
|
Guanidine carbonate, 97% (titr.)
| 593-85-1 |
|
4-Ethoxy-3-Methoxybenzaldehyde, 95%
| 120-25-2 |
|
Magnesium sulfate heptahydrate
| 7487-88-9 |
|
3-(N-Benzyl-N-methylamino)-1,2-propanediol 96+%
| 60278-98-0 |
|
Maleic acid
| 110-16-7 |
|
Malonic acid
| 141-82-2 |
|
Oil for Heat Transfer
| 0-01-1 |
|
D-(+)-Maltose Monohydrate
| 69-79-4 |
|
Manganese(II) chloride tetrahydrate
| 7773-01-5 |
|
2-Aminobenzimidazole, 95% (titr.)
| 934-32-7 |
|
Manganese (IV) Dioxide
| 1313-13-9 |
|
Cesium Fluoride, 99%
| 13400-13-0 |
|
2,2'-Dipyridylamine, 99%
| 1202-34-2 |
|
Manganese (II) Nitrate Solution
| 7697-37-2 |
|
Methylglyoxal bis-(guanyl-hydrazone) dihydrochloride monohydrate,
| 24968-67-0 |
|
N-Methyl-D-Glucamine, 99%
| 6284-40-8 |
|
1,5-Dibromopentane, 97%
| 111-24-0 |
|
Manganese(II) sulfate monohydrate
| 7785-87-7 |
|
Pentachloropyridine, 98%
| 2176-62-7 |
|
Mannitol
| 69-65-8 |
|
N,N-Dimethyl-O-Phenylenediamine Dihydrochloride, 99% (Titr.)
| 62654-07-3 |
|
Trimethyltin chloride, 99%
| 1066-45-1 |
|
Salicylamide, 99%
| 65-45-2 |
|
5-alpha-Cholestane, 98+%
| 481-21-0 |
|
2-Methyl-5-nitroimidazole, 99%
| 88054-22-2 |
|
2-Mercaptoethanol
| 60-24-2 |
|
Mercury(II) acetate
| 1600-27-7 |
|
Cytidine-2'(3')-Monophosphoric Acid, 99+%
| 84-52-6 |
|
Cis-2-Hydroxy-1-Cyclopentanecarboxamide 99+%
| 40481-98-9 |
|
Fast Blue B Salt
| 14263-94-6 |
|
M-Nitrocinnamic Acid, 99%, Predominantly Trans
| 555-68-0 |
|
|